I am the lead Academic Urologist at Zimbabwe's Premier Academic Health Training Institution, home to Africa's most comprehensive Prostate Cancer registry since 1985. I am seeking uro-academic, imaging, and next-generation genome research partners for pioneering prostate cancer research targeting a population of 15 million.

Zimbabwe is ideal for whole genome sequencing to identify significant cancers in the 40-70 age group, alongside studying the microbiome's role in prostate cancer genesis. Due to low diagnostic and therapeutic intervention penetration, this population is suited for next-generation MRI-guided biopsy and metastasis determination. We anticipate the initial study, accessing early and late-stage prostate cancer patients, will be completed in 12 months.

Regards

Athanasius Daud Dube

BSc (Intercalated: Hon's Medical Physiology, Queen’s Belfast)  MRCS (Eng)   LRCP (Lond)  FRCS (Edin)  FRPS.RCS (Glasg)    D.Urol (Lond)  PCCS: APCCS (Harvard), PLME (Harvard Macy.NUS.Harvard)

DIRECTOR/UNIT COORDINATOR: UROLOGY TRAINING  PROGRAMME[UTP]

DEPARTMENT OF SURGICAL SCIENCES[DSS]

UNIVERSITY OF ZIMBABWE FACULTY OF MEDICINE AND  HEALTH  SCIENCES(UZ-FMHS)

[email protected]> Tel: +263780043674//+263791631

More Athanasius Daud Dube's questions See All
Similar questions and discussions